$186.6 M

KRYS Mkt cap, 20-Sep-2018
Krystal Biotech Net income (FY, 2016)-1.1 M
Krystal Biotech EBIT (FY, 2016)-1.1 M
Krystal Biotech Cash, 31-Dec-20161.9 M

Krystal Biotech Income Statement

Annual

USDFY, 2016

R&D expense

741 k

General and administrative expense

402 k

Operating expense total

1.1 m

EBIT

(1.1 m)

Interest expense

7 k

Net Income

(1.2 m)

Krystal Biotech Balance Sheet

Annual

USDFY, 2016

Cash

1.9 m

Prepaid Expenses

246 k

Current Assets

2.2 m

PP&E

13 k

Total Assets

2.2 m

Accounts Payable

42 k

Current Liabilities

43 k

Total Liabilities

1.9 m

Additional Paid-in Capital

33 k

Retained Earnings

(1.2 m)

Total Equity

289 k

Financial Leverage

7.6 x

Krystal Biotech Cash Flow

Annual

USDFY, 2016

Net Income

(1.2 m)

Depreciation and Amortization

2 k

Cash From Operating Activities

(1.3 m)

Purchases of PP&E

(15 k)

Cash From Investing Activities

(15 k)

Cash From Financing Activities

3.2 m

Net Change in Cash

1.9 m

Krystal Biotech Ratios

USDY, 2016

Financial Leverage

7.6 x
Report incorrect company information